A randomized, multicenter phase 2 study of DSP-7888 dosing emulsion in combination with bevacizumab (Bev) versus Bev alone in patients with recurrent or progressive glioblastoma

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 36; no. 15_suppl; p. TPS2071
Main Authors De Groot, John Frederick, Cloughesy, Timothy Francis, Pitz, Marshall W., Narita, Yoshitaka, Nonomura, Takeshi
Format Journal Article
LanguageEnglish
Published 20.05.2018
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/JCO.2018.36.15_suppl.TPS2071